IMPAX Laboratories to Hold Third Quarter Financial Results Conference Call Monday, October 28

October 22, 2002

October 22, 2002 -- IMPAX Laboratories, Inc. (Nasdaq NM: IPXL) today announced that the Company will release its financial results for the third quarter of 2002 on Monday, October 28, 2002.

Barry R. Edwards, co-chief executive officer, and Cornel C. Spiegler, chief financial officer, will host an investment-community conference call beginning at 2:00 p.m. Eastern Time (11 a.m. Pacific Time) to discuss these results and to answer questions.

To participate in the live call by telephone, please dial (888) 803-7396 from the U.S., or for international callers, please dial (706) 634-1052.

Those interested in listening to the conference call live via the Internet may do so by visiting the Company's Web site at www.impaxlabs.com. To listen to the live call, please go to the Website 15 minutes prior to its start to register, download, and install the necessary audio software.

A replay will be available on the Company Web site for 14 days. A telephone replay will be available for 48 hours by dialing (800) 642-1687 from the U.S., or (706) 645-9291 for international callers, and entering reservation 6297437.

IMPAX Laboratories, Inc. is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and niche generics in addition to the development of branded products. IMPAX markets its generic products through its Global Pharmaceuticals division and intends to market its branded products through the IMPAX Pharmaceuticals division. IMPAX Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward and Philadelphia facilities. For more information, please visit the Company's Web site at: www.impaxlabs.com.